Ab&B Bio-Tech Updates Board Composition and Committee Assignments

Bulletin Express
05/27

Ab&B Bio-Tech CO., LTD. JS announced the latest configuration of its Board of Directors and the corresponding committee assignments. The Board now comprises eight members, including three executive directors, two non-executive directors, and three independent non-executive directors.

Executive leadership is headed by Chairman Mr. An Youcai, who also chairs the Strategy Committee. The other executive directors are Ms. Li Runxiang and Mr. He Yiming.

Non-executive representation consists of Mr. Yu Jianlin and Mr. Du Mu.

Independent oversight is provided by Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei, and Ms. Lui Mei Ka.

Committee leadership is structured as follows: • Audit Committee – chaired by Mr. Li Jianjun • Remuneration and Appraisal Committee – chaired by Mr. Chen Chengbei • Nomination Committee – chaired by Mr. Li Xiangming • Strategy Committee – chaired by Mr. An Youcai

The disclosure reiterates Ab&B Bio-Tech’s adherence to corporate governance guidelines by clearly defining responsibilities across its four key committees.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10